Development of a core outcome set for multimorbidity trials in low/middle-income countries (COSMOS): study protocol
Open Access
Abstract
Introduction ‘Multimorbidity’ describes the presence of two or more long-term conditions, which can include communicable, non-communicable diseases, and mental disorders. The rising global burden from multimorbidity is well documented, but trial evidence for effective interventions in low-/middle-income countries (LMICs) is limited. Selection of appropriate outcomes is fundamental to trial design to ensure cross-study comparability, but there is currently no agreement on a core outcome set (COS) to include in trials investigating multimorbidity specifically in LMICs. Our aim is to develop international consensus on two COSs for trials of interventions to prevent and treat multimorbidity in LMIC settings. Methods and analysis Following methods recommended by the Core Outcome Measures in Effectiveness Trials initiative, the development of these two COSs will occur in parallel in three stages: (1) generation of a long list of potential outcomes for inclusion; (2) two-round online Delphi surveys and (3) consensus meetings. First, to generate an initial list of outcomes, we will conduct a systematic review of multimorbidity intervention and prevention trials and interviews with people living with multimorbidity and their caregivers in LMICs. Outcomes will be classified using an outcome taxonomy. Two-round Delphi surveys will be used to elicit importance scores for these outcomes from people living with multimorbidity, caregivers, healthcare professionals, policy makers and researchers in LMICs. Finally, consensus meetings including all of these stakeholders will be held to agree outcomes for inclusion in the two COSs. Ethics and dissemination The study has been approved by the Research Governance Committee of the Department of Health Sciences, University of York, UK (HSRGC/2020/409/D:COSMOS). Each participating country/research group will obtain local ethics board approval. Informed consent will be obtained from all participants. We will disseminate findings through peer-reviewed open access publications, and presentations at global conferences selected to reach a wide range of LMIC stakeholders. PROSPERO registation number CRD42020197293.Keywords
All Related Versions
Funding Information
- National Institute for Health Research (National Institute for Health Research (Grant: 17/63/130: NIHR Global Health Research Group))
This publication has 40 references indexed in Scilit:
- Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transitionThe Lancet, 2015
- Multimorbidity in Patients Attending 2 Australian Primary Care PracticesThe Annals of Family Medicine, 2013
- Developing core outcome sets for clinical trials: issues to considerTrials, 2012
- The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. first results from the multicare cohort studyBMC Health Services Research, 2012
- The impact of mental illness on potentially preventable hospitalisations: a population-based cohort studyBMC Psychiatry, 2011
- When are complex interventions 'complex'? When are simple interventions 'simple'?European Journal of Public Health, 2011
- GRADE guidelines: 2. Framing the question and deciding on important outcomesJournal of Clinical Epidemiology, 2011
- What is an adequate sample size? Operationalising data saturation for theory-based interview studiesPsychology & Health, 2010
- Prevalence of Chronic Diseases and Multimorbidity Among the Elderly Population in SwedenAmerican Journal of Public Health, 2008
- Qualitative Research: Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services researchBMJ, 1995